Valuation (83%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -8.80 | 9.44 |
PEG Ratio (TTM) | 0.26 | -1.42 |
P/S Ratio (TTM) | 0.77 | 7.15 |
P/B Ratio (TTM) | 0.87 | 34.72 |
P/FCF Ratio (TTM) | 11.36 | 17.38 |
Price to 5YR AVG Earnings Ratio | 2.19 | -2.67 |
Price to 5YR AVG FCF Ratio | 29.13 | 59.43 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.91% | 0.09% |
ROE (TTM) | -9.46% | -141.70% |
Net Profit Margin (TTM) | -8.75% | 1.47% |
ROIC 5YR AVG | 6.49% | 31.54% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -231.01% | 227.21% | 85.76% |
Revenue | -1.51% | 13.90% | 9.96% |
Net Income | -226.18% | 94.08% | 1.51% |
Cash Flow | 36.57% | 0.79% | 11.17% |
Health (86%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.16 | 2.65 |
Quick Ratio (TTM) | 4.16 | 2.64 |
D/E Ratio (TTM) | 0.01 | 0.80 |
Interest Coverage (TTM) | N/A | 1.25 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 3.57 | 4.45 |
LTL to 5YR AVG FCF | 0.64 | 3.88 |
Shares Outstanding Growth 5YR AVG | -7.06% | 7.01% |